Magoneko Solutions Begins Business Development Support for SmarTrial in Japan

June 1, 2026

Magoneko Solutions Co., Ltd. has entered into a Business Development Support Agreement with SmarTrial Inc., the provider of the clinical trial productivity platform "SmarTrial," and has commenced business development support activities in Japan.

SmarTrial(Web site: https://lp.smartrial.jp/en/

SmarTrial is a platform designed to improve productivity across clinical trial operations by streamlining communication and project management. It facilitates information sharing among sponsors, CROs, SMOs, and medical institutions, helping to enhance operational efficiency and quality throughout the clinical trial process.

Through this agreement, Magoneko Solutions will support SmarTrial's business development activities in Japan and contribute to increasing awareness and adoption of the solutions provided by SmarTrial.

By leveraging our expertise in clinical trial operations, EDC build services, and digital solutions, we will further promote initiatives that contribute to improving the efficiency and quality of clinical development activities.

We will continue to identify and introduce innovative solutions that address our clients' needs and contribute to the advancement of clinical trials and clinical research.

Further information regarding the product, our portfolio, and its position within our solution map will be available on our Solution page in the future.

Minoru Takada
President & CEO